Literature DB >> 20930521

Making sense of ubiquitin ligases that regulate p53.

Abhinav K Jain1, Michelle Craig Barton.   

Abstract

The functions of p53 most highly associated with the well-studied tumor suppressor are its abilities to induce cell cycle arrest and apoptosis in response to cellular stresses. Recent progress underscores that p53 is a multi-functional protein with activities that range beyond tumor suppression to normal homeostasis, metabolism, fertility and differentiation. A unifying theme of these studies is that p53 is first and foremost a transcription factor; and control of p53 protein stability determines its ability to carry out this task. There are an expanding number of E3-ubiquitin ligase proteins that target p53 for ubiquitin tagging and protein degradation. This review discusses these many effectors of p53 protein degradation, and our task is to provide some level of understanding as to their differences and their similarities. Further, we propose how some degree of specialization may be assigned to the E3-ligases, in their navigation toward a common goal of regulating p53 protein levels, and emphasize that better understanding of the mechanisms involved in E3-ligase functions is needed to further their potential as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930521      PMCID: PMC3023569          DOI: 10.4161/cbt.10.7.13445

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  88 in total

Review 1.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

2.  Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability.

Authors:  Won Ho Yang; Ji Eun Kim; Hyung Wook Nam; Jung Won Ju; Hoe Suk Kim; Yu Sam Kim; Jin Won Cho
Journal:  Nat Cell Biol       Date:  2006-09-10       Impact factor: 28.824

3.  Regulation of p53 localization and activity by Ubc13.

Authors:  Aaron Laine; Ivan Topisirovic; Dayong Zhai; John C Reed; Katherine L B Borden; Ze'ev Ronai
Journal:  Mol Cell Biol       Date:  2006-09-25       Impact factor: 4.272

4.  Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.

Authors:  Rajesh K Singh; Saravanakumar Iyappan; Martin Scheffner
Journal:  J Biol Chem       Date:  2007-02-14       Impact factor: 5.157

5.  C-terminal modifications regulate MDM2 dissociation and nuclear export of p53.

Authors:  Stephanie Carter; Oliver Bischof; Anne Dejean; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2007-03-18       Impact factor: 28.824

Review 6.  Lessons from p53 in non-mammalian models.

Authors:  W-J Lu; J M Abrams
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

7.  Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.

Authors:  Linghu Nie; Mark Sasaki; Carl G Maki
Journal:  J Biol Chem       Date:  2007-03-19       Impact factor: 5.157

8.  Cytoplasmic localized ubiquitin ligase cullin 7 binds to p53 and promotes cell growth by antagonizing p53 function.

Authors:  P Andrews; Y J He; Y Xiong
Journal:  Oncogene       Date:  2006-03-20       Impact factor: 9.867

Review 9.  How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?

Authors:  A Olsson; C Manzl; A Strasser; A Villunger
Journal:  Cell Death Differ       Date:  2007-07-13       Impact factor: 15.828

Review 10.  p53 and its isoforms in cancer.

Authors:  J-C Bourdon
Journal:  Br J Cancer       Date:  2007-07-17       Impact factor: 7.640

View more
  30 in total

1.  Regulation of the ubiquitylation and deubiquitylation of CREB-binding protein modulates histone acetylation and lung inflammation.

Authors:  Jianxin Wei; Su Dong; Rachel K Bowser; Andrew Khoo; Lina Zhang; Anastasia M Jacko; Yutong Zhao; Jing Zhao
Journal:  Sci Signal       Date:  2017-06-13       Impact factor: 8.192

2.  TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage.

Authors:  Abhinav K Jain; Kendra Allton; Aundrietta D Duncan; Michelle C Barton
Journal:  Mol Cell Biol       Date:  2014-07       Impact factor: 4.272

3.  Role of HSPA1L as a cellular prion protein stabilizer in tumor progression via HIF-1α/GP78 axis.

Authors:  J H Lee; Y-S Han; Y M Yoon; C W Yun; S P Yun; S M Kim; H Y Kwon; D Jeong; M J Baek; H J Lee; S-J Lee; H J Han; S H Lee
Journal:  Oncogene       Date:  2017-07-31       Impact factor: 9.867

4.  p53-Pirh2 Complex Promotes Twist1 Degradation and Inhibits EMT.

Authors:  Yang Yang-Hartwich; Roslyn Tedja; Cai M Roberts; Jamie Goodner-Bingham; Carlos Cardenas; Marta Gurea; Natalia J Sumi; Ayesha B Alvero; Carlotta A Glackin; Gil Mor
Journal:  Mol Cancer Res       Date:  2018-08-21       Impact factor: 5.852

Review 5.  Attenuating the p53 Pathway in Human Cancers: Many Means to the Same End.

Authors:  Amanda R Wasylishen; Guillermina Lozano
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

6.  Emerging roles of long non-coding RNAs in the p53 network.

Authors:  Abhinav K Jain
Journal:  RNA Biol       Date:  2020-06-04       Impact factor: 4.652

Review 7.  Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.

Authors:  Domagoj Vucic; Vishva M Dixit; Ingrid E Wertz
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06-23       Impact factor: 94.444

Review 8.  Regulation of MDM2 Stability After DNA Damage.

Authors:  Jiaqi Li; Manabu Kurokawa
Journal:  J Cell Physiol       Date:  2015-10       Impact factor: 6.384

9.  RNF2/Ring1b negatively regulates p53 expression in selective cancer cell types to promote tumor development.

Authors:  Wen-jing Su; Jun-shun Fang; Feng Cheng; Chao Liu; Fang Zhou; Jian Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

Review 10.  The Roles of MDM2 and MDMX in Cancer.

Authors:  Orit Karni-Schmidt; Maria Lokshin; Carol Prives
Journal:  Annu Rev Pathol       Date:  2016-03-17       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.